Latest:
Dr. Soliman the Utility of ADCs in Breast Cancer
Hatem Soliman, MD, discusses the utility of antibody-drug conjugates in breast cancer.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Hatim Husain, MD
Latest:
Charting the Future: Key Therapies for Managing EGFR-Mutant NSCLC
This episode focuses on exploring additional therapeutic options for managing previously treated advanced or metastatic EGFR-mutated NSCLC, highlighting strategies to optimize patient survival across various stages of disease progression.
Haythem Y. Ali, MD
Latest:
Dr. Ali on the Need to Understand Real-World Disparities in BRCA Testing in TNBC
Haythem Y. Ali, MD, member, Henry Ford Cancer Institute, Henry Ford Health System, discusses the need to understand real-world disparities with BRCA testing referrals and uptake in patients with triple-negative breast cancer.
Heather A. Wakelee, MD, FASCO
Latest:
Monitoring Patients With RET-Positive NSCLC
Panelists discuss how to monitor patients for response to treatment and early signs of resistance in RET fusion–positive non–small cell lung cancer (NSCLC), including the approach to follow-up molecular testing, and describe strategies for treatment sequencing after disease progression on RET inhibitors.
Heather A. Wakelee, MD, Stanford University Medical Center
Latest:
Experts on the Evaluation of CEACAM5-Targeted Therapy in NSCLC
Balazs Halmos, MD, Martin F. Dietrich, MD, PhD, Roy S. Herbst, MD, PhD, Suresh S. Ramalingam, MD, FACP, FASCO, Mark Socinski, MD, and Heather Wakelee, MD, FASCO, discuss the evaluation of CEACAM5 biomarker testing in non–small cell lung cancer.
Heather A. Zierhut, PhD, MS, CGC
Latest:
New Law Widens Access to Genetic Counseling but Licensure and Coverage Barriers Persist
Telehealth, a universal term for the use of digital information and communication technologies to remotely access healthcare services, is improving availability of healthcare services, particularly for patients in rural areas.